The Evolving Role of Immune-Checkpoint Inhibitors in Malignant Pleural Mesothelioma

Malignant pleural mesothelioma (MPM) is a rare cancer usually caused by asbestos exposure and associated with a very poor prognosis. After more than a decade without new therapeutic options, immune checkpoint inhibitors (ICIs) demonstrated superiority over standard chemotherapy, with improved overal...

Descripción completa

Detalles Bibliográficos
Autores principales: Borgeaud, Maxime, Kim, Floryane, Friedlaender, Alex, Lococo, Filippo, Addeo, Alfredo, Minervini, Fabrizio
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10003250/
https://www.ncbi.nlm.nih.gov/pubmed/36902544
http://dx.doi.org/10.3390/jcm12051757

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10003250/
https://www.ncbi.nlm.nih.gov/pubmed/36902544
http://dx.doi.org/10.3390/jcm12051757

Ejemplares similares